Milbemycin Oxime,Spinosad

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Milbemycin Oxime,Spinosad

Administration Routes

OralUnknown

Species Affected

Dog 16

Most Affected Breeds

Retriever - Labrador 4

Ridgeback - Rhodesian 2

Shiba Inu 1

Shepherd Dog - German 1

Bulldog - American 1

Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Chihuahua 1

Terrier (unspecified) 1

Poodle (unspecified) 1

Dachshund (unspecified) 1

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 7

Lethargy (see also Central nervous system depression in Neurological) 5

Decreased appetite 3

Vomiting 3

Diarrhoea 3

Tremor 2

Allergic pruritus 1

Vocalisation 1

Decreased bowel movements 1

Hyperactivity 1

Urinary incontinence 1

Scooting 1

Outcome Breakdown

Outcome Unknown

9 (56.3%)

Recovered/Normal

5 (31.3%)

Ongoing

2 (12.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.